Abstract
To investigate the association between Korean red ginseng (KRG) intake in HIV-1 infected patients and the occurrence of grossly deleted nef genes (gΔnef), we characterized nef genes in 10 long-term slow progressors (LTSP) infected with HIV-1 subtype B and 34 control patients. LTSP was defined by the annual decrease in CD4 T cells being less than 20/μl over 10 years in the absence of antiretroviral therapy. They were treated with KRG for a prolonged period. Nef genes were amplified from peripheral blood mononuclear cells (PBMC) using nested PCR and the products were sequenced directly. It was observed that the patients CD4 T cell counts decreased from 444 ± 207/μl to 294 ± 177/μl over 136 ± 23 months of KRG intake. This corresponds to an annual decrease in the level of CD4 T cells of 13.3/μl. A total of 479 nef genes were amplified from 137 PBMC samples. Nine out of the 10 patients, 47 (34.3 %) out of the 137 samples, and 90 out of the 479 genes revealed gΔnef. The deletion extended outside the nef gene in 25 gΔnef obtained from 6 patients. The proportion of samples with gΔnef (34.3 %) was significantly higher than 4.8 % in control patients (P < 0.001). In addition, it significantly increased as the duration of KRG intake prolongs (P < 0.01). These data suggest that the occurrence of g nef might be associated with long-term intake of KRG.
Keywords: Korean red ginseng, HIV-1 subtype B, long-term slow progressor, Grossly deleted nef
Current HIV Research
Title: High Frequency of Grossly Deleted nef Genes in HIV-1 Infected Long-Term Slow Progressors Treated with Korean Red Ginseng
Volume: 4 Issue: 4
Author(s): Heungsup Sung, Hee J. Lee, Ji Y. Lim, You S. Jung, Sun K. Oh, Young K. Cho, Ji Y. Lim, You S. Jung, Sun K. Oh and Hee J. Lee
Affiliation:
Keywords: Korean red ginseng, HIV-1 subtype B, long-term slow progressor, Grossly deleted nef
Abstract: To investigate the association between Korean red ginseng (KRG) intake in HIV-1 infected patients and the occurrence of grossly deleted nef genes (gΔnef), we characterized nef genes in 10 long-term slow progressors (LTSP) infected with HIV-1 subtype B and 34 control patients. LTSP was defined by the annual decrease in CD4 T cells being less than 20/μl over 10 years in the absence of antiretroviral therapy. They were treated with KRG for a prolonged period. Nef genes were amplified from peripheral blood mononuclear cells (PBMC) using nested PCR and the products were sequenced directly. It was observed that the patients CD4 T cell counts decreased from 444 ± 207/μl to 294 ± 177/μl over 136 ± 23 months of KRG intake. This corresponds to an annual decrease in the level of CD4 T cells of 13.3/μl. A total of 479 nef genes were amplified from 137 PBMC samples. Nine out of the 10 patients, 47 (34.3 %) out of the 137 samples, and 90 out of the 479 genes revealed gΔnef. The deletion extended outside the nef gene in 25 gΔnef obtained from 6 patients. The proportion of samples with gΔnef (34.3 %) was significantly higher than 4.8 % in control patients (P < 0.001). In addition, it significantly increased as the duration of KRG intake prolongs (P < 0.01). These data suggest that the occurrence of g nef might be associated with long-term intake of KRG.
Export Options
About this article
Cite this article as:
Sung Heungsup, Lee J. Hee, Lim Y. Ji, Jung S. You, Oh K. Sun, K. Cho Young, Y. Lim Ji, S. Jung You, K. Oh Sun and J. Lee Hee, High Frequency of Grossly Deleted nef Genes in HIV-1 Infected Long-Term Slow Progressors Treated with Korean Red Ginseng, Current HIV Research 2006; 4 (4) . https://dx.doi.org/10.2174/157016206778560072
DOI https://dx.doi.org/10.2174/157016206778560072 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Crosstalk Signalling Role in Modulation of Drugs Side Effects
Current Molecular Pharmacology In Silico Approaches to the Design of NS5A Inhibitors
Current Topics in Medicinal Chemistry Progress and Outlooks in a Genetic Absence Epilepsy Model (WAG/Rij)
Current Medicinal Chemistry Nimesulide Apparent Solubility Enhancement with Natural Cyclodextrins and their Polymers
Letters in Drug Design & Discovery Pharmacogenetics of Selective Serotonin Reuptake Inhibitor Response in Major Depression
Current Pharmacogenomics Deciphering Transcriptional Regulation Relevant to Eating Behavior
Current Genomics Phosphoryl Chloride Mediated Synthesis of 5-Arylidene-2,4-Thiazolidinediones Derivatives via Aromatic Bisulfite Adducts
Letters in Organic Chemistry Immune Response to Mycobacteria
Current Immunology Reviews (Discontinued) Inflammation in Arthropods
Current Pharmaceutical Design Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Beta Cell Regeneration
Current Diabetes Reviews Recent Advances in T Cell Adoptive Immunotherapy of Cancer
Current Cancer Therapy Reviews siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector
Current Pharmaceutical Design In silico Structural and Functional Analysis of Arabidopsis thaliana’s XPB Homologs
Current Proteomics Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis
Current Pharmaceutical Design Novel Research Strategies of Benzimidazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Novel Therapeutic Strategies Targeting Vascular Redox in Human Atherosclerosis
Recent Patents on Cardiovascular Drug Discovery Candida Infections and Human Defensins
Protein & Peptide Letters Same Target, Different Therapeutic Outcomes: The Case of CAY10471 and Fevipiprant on CRTh2 Receptor in Treatment of Allergic Rhinitis and Asthma
Combinatorial Chemistry & High Throughput Screening Vascular Pharmacotherapy and Dementia
Current Vascular Pharmacology